BioCentury
ARTICLE | Company News

Galen, Gilead sales and marketing update

March 5, 2012 8:00 AM UTC

Galen's Galen US Inc. subsidiary acquired exclusive, worldwide rights to Gilead's DaunoXome. The liposomal formulation of daunorubicin is approved in the U.S. to treat AIDS/HIV-associated Kaposi's sa...